Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: DAI Global LLC
Street 1: 7600 Wisconsin Avenue
Street 2: Suite 200
City: Bethesda,
Province: Maryland
Post Code: 20814
Country: United States of America
Phone: 001 301 771 7600
Email: bobby_jefferson@dai.com
Web Site: http://www.dai.com

Focal Point Contact Information

Salutation: Mr
First Name: Bobby
Last Name: Jefferson
Title: Chief Technology Officer
Email: bobby_jefferson@dai.com
Phone: 001 301 771 7600

Alternate Focal Point Contact Information

Salutation: Ms
First Name: Chetna
Last Name: Chawla
Title: Technology Director
Email: chetna_chawla@dai.com
Phone: +919810352372

General Information

Board Constituency: None
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
Mission and Main focus : DAI is a global development company that works on the frontlines of international development, tackling fundamental social and economic development problems caused by inefficient markets, ineffective governance, and instability. Committed to shaping a more livable world.
Why are you interested in TB: We implement projects within TB components and other health sectors around the world.
What are you ding or planning to do for TB control : We are implementing projects with TB components and plan to continue doing so in future through implementing innovative solutions that support detection and treatment.
 
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 6 - 10
Number of part-time staff who are directly involved with TB: 1 - 5
Number of volunteers who are directly involved with TB: 0
 
What is your organization's annual budget (USD) dedicated to TB? Unable to disclose amount
How did you hear about the Stop TB Partnership: Attendance at a TB related event
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Information on developments within the TB world
 
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
We are implementing innovative patent centered solutions in Haiti that manage patient level data, integrating HIV co-infected patients thereby improving quality of care for TB.
 

Geographical Reach

Which country is your headquarters located in: United States of America
Which WHO region is the main focus of your work: Global
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Afghanistan
Albania
Algeria
Armenia
Azerbaijan
Bangladesh
Bhutan
Cambodia
Central African Republic
Chad
Cote d'Ivoire
Dominica
El Salvador
Eswatini
Ethiopia
Ghana
Guatemala
Guinea
Haiti
Indonesia
Iran (Islamic Republic of)
Jamaica
Kazakhstan
Kenya
Kyrgyzstan
Liberia
Malawi
Mali
Mauritania
Mozambique
Myanmar
Namibia
Nepal
Nigeria
Pakistan
Papua New Guinea
Philippines
Rwanda
Senegal
South Africa
South Sudan
Sudan
Tajikistan
Thailand
Turkmenistan
Uganda
United Republic of Tanzania
Uzbekistan
Viet Nam
Zambia
Zimbabwe

Specializations

Advocacy
Civil Society and Community Engagement
Delivery of health services and care
Technical Assistance

Specializations in Countries

Delivery of health services and care Indonesia
Delivery of health services and care Kenya
Delivery of health services and care Malawi
Delivery of health services and care Nigeria
Delivery of health services and care Zambia
Technical Assistance Afghanistan
Technical Assistance Albania
Technical Assistance Algeria
Technical Assistance Armenia
Technical Assistance Azerbaijan
Technical Assistance Bangladesh
Technical Assistance Bhutan
Technical Assistance Cambodia
Technical Assistance Central African Republic
Technical Assistance Chad
Technical Assistance Cote d'Ivoire
Technical Assistance Dominica
Technical Assistance El Salvador
Technical Assistance Eswatini
Technical Assistance Ethiopia
Technical Assistance Ghana
Technical Assistance Guatemala
Technical Assistance Guinea
Technical Assistance Haiti
Technical Assistance Indonesia
Technical Assistance Iran (Islamic Republic of)
Technical Assistance Jamaica
Technical Assistance Kazakhstan
Technical Assistance Kenya
Technical Assistance Kyrgyzstan
Technical Assistance Liberia
Technical Assistance Malawi
Technical Assistance Mali
Technical Assistance Mauritania
Technical Assistance Mozambique
Technical Assistance Myanmar
Technical Assistance Namibia
Technical Assistance Nepal
Technical Assistance Nigeria
Technical Assistance Pakistan
Technical Assistance Papua New Guinea
Technical Assistance Philippines
Technical Assistance Rwanda
Technical Assistance Senegal
Technical Assistance South Africa
Technical Assistance South Sudan
Technical Assistance Sudan
Technical Assistance Tajikistan
Technical Assistance Thailand
Technical Assistance Turkmenistan
Technical Assistance Uganda
Technical Assistance United Republic of Tanzania
Technical Assistance Uzbekistan
Technical Assistance Viet Nam
Technical Assistance Zambia
Technical Assistance Zimbabwe

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
Innovative patent-centric solutions that support detection and treatment

Drug-Resistant TB:
Specific modules developed that encompass patient-level data respectively on sensible Tb, multi-drug resistant Tb, patients receiving prophylaxy to INH, and person in contact with bacteriologically confirmed pulmonary TB patients.

TB-HIV:
Integration modules that track HIV co-infection

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: March 21, 2018
Last updated: March 21, 2018